los consumidores cuentan con plazos especficos para reclamar ante cualquier inconveniente relacionado tanto con la recepcin del producto como posibles fallas en l despus del recibimiento
This supplement contains micronized creatine and nothing elseno fillers or additives
Key points GLP-1 is a hormone that increases insulin release and prevents the release of too much glucagon, helping manage blood glucose levels in individuals with type 2 diabetes GLP-1 receptor agonists, such as liraglutide and semaglutide, effectively reduce blood glucose levels Semaglutide is more effective than liraglutide at reducing blood sugar levels Tirzepatide is a newer GLP-1 receptor agonist that also mimics the actions of another hormone called GIP, which can also reduce blood sugar levels A randomised controlled trial showed that tirzepatide led to more significant blood sugar reductions than semaglutide across three doses Tirzepatide may be more effective than semaglutide at higher doses, but this needs further investigation Liraglutide and semaglutide are available in the UK and the US, while tirzepatide is only available in the US but is likely to be approved in the UK soon
Monitoring requires baseline and ongoing liver function tests, FIB-4 scoring for fibrosis risk, and vigilance for pancreatitis and gallbladder disease
Frequently Asked Questions What are the most common longterm side effects of GLP1 therapy
There was no need to evaluate the inconsistency between the direct (any class of drugs vs another class) and indirect (any class of drugs vs placebo) effects in the network meta-analysis, as there was no trial that compared any two classes in all the trials
